Funding Clinical Trials
Funding Clinical Trials
Our Agency funds clinical trials testing promising stem cell-based treatments for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.
CIRM Clinical Dashboard
Disease Areas |
Investigator | Organization | Phase | Trial Status | Targeted Enrollment | Detail |
|---|---|---|---|---|---|---|
| Jeffrey Lawson | Humacyte, Inc. | Phase 3 | Active, not recruiting | 355 | ||
| Samuel Strober | Stanford University | Phase 1 | Active, not recruiting | 15 | ||
| Jeffrey Lawson | Humacyte, Inc. | Phase 3 | Recruiting | 240 | ||
| Daniel Brennan | Medeor Therapeutics, Inc. | Phase 3 | Active, not recruiting | 30 | ||
| Everett Meyer | Stanford University | Phase 1 | Recruiting | 22 | ||
| Stephanie Cherqui | University of California, San Diego | Phase 1/2 | Recruiting | 6 |
